Corus Pharma, Inc.

Calculating rank

USPTO Granted Patents = 5

CIPO Patents = 3

EPO Patents = 1

Trademarks = 1

Forward Citations = 35

Loading Chart...

7 inventors (with patents filed for the assignee):

Alan Bruce Montgomery (3 out of 27 patents)

Claude Singer (2 out of 36 patents)

Csaba Szabo (2 out of 21 patents)

4. Viktor Gyollai (2 out of 6 patents)

5. Istvan Bodi (2 out of 3 patents)

6. Iain W Duncan (1 out of 5 patents)

7. Peter Carbonaro (1 out of 1 patent)

8. David MacLeod (4 patents)

9. William Baker (0 patent)

10. David Macleod (0 patent)

11. William Ph D Corus Pharma Baker (0 patent)

5 patents: Sort by Forward Citations

1. 7358093 - Aztreonam L-lysine and methods for the preparation and analysis thereof (2008-04-15),

2. 7262293 - Aztreonam L-lysine and methods for the preparation thereof (2007-08-28),

3. 7214364 - Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections (2007-05-08),

4. 7208141 - Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections (2007-04-24),

5. 7138419 - Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate (2006-11-21),

Company Overview

Corus Pharma, Inc. is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases. With a dedication to improving the lives of patients with serious lung conditions, Corus Pharma is committed to advancing breakthrough treatments. The company's pipeline includes novel compounds targeting various respiratory disorders, such as asthma and chronic obstructive pulmonary disease (COPD).

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#356 in Seattle, WA

#1,242 in Washington

#51,669 in US

Seattle, WA, United States of America

Corus Pharma, Inc.

Forward Citations = 35

7 inventors:

Alan Bruce Montgomery (3 out of 27 patents)

Claude Singer (2 out of 36 patents)

Csaba Szabo (2 out of 21 patents)

4. Viktor Gyollai (2 out of 6 patents)

5. Istvan Bodi (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corus Pharma, Inc.. Retrieved from https://idiyas.com/company/corus-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]